NO177139C - Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-amidoindolylderivater - Google Patents
Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-amidoindolylderivaterInfo
- Publication number
- NO177139C NO177139C NO914300A NO914300A NO177139C NO 177139 C NO177139 C NO 177139C NO 914300 A NO914300 A NO 914300A NO 914300 A NO914300 A NO 914300A NO 177139 C NO177139 C NO 177139C
- Authority
- NO
- Norway
- Prior art keywords
- amidoindolyl
- derivatives
- preparation
- therapeutically active
- analogous process
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Paints Or Removers (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60845790A | 1990-11-02 | 1990-11-02 | |
| US76753191A | 1991-10-02 | 1991-10-02 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO914300D0 NO914300D0 (no) | 1991-11-01 |
| NO914300L NO914300L (no) | 1992-05-04 |
| NO177139B NO177139B (no) | 1995-04-18 |
| NO177139C true NO177139C (no) | 1995-07-26 |
Family
ID=27085774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO914300A NO177139C (no) | 1990-11-02 | 1991-11-01 | Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-amidoindolylderivater |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0483881B1 (de) |
| JP (1) | JP3168565B2 (de) |
| KR (1) | KR100220882B1 (de) |
| AT (1) | ATE162519T1 (de) |
| AU (1) | AU641052B2 (de) |
| CA (1) | CA2054339C (de) |
| DE (1) | DE69128764T2 (de) |
| DK (1) | DK0483881T3 (de) |
| ES (1) | ES2113359T3 (de) |
| FI (1) | FI102676B (de) |
| GR (1) | GR3026349T3 (de) |
| HU (1) | HU214597B (de) |
| IE (1) | IE913834A1 (de) |
| IL (1) | IL99908A (de) |
| NO (1) | NO177139C (de) |
| NZ (1) | NZ240380A (de) |
| PT (1) | PT99400B (de) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4242675A1 (de) * | 1992-12-17 | 1994-06-23 | Basf Ag | Neue Hydroxyiminoalkylindolcarbonsäure-Derivate, ihre Herstellung und Verwendung |
| GB9311948D0 (en) * | 1993-06-10 | 1993-07-28 | Zeneca Ltd | Substituted nitrogen heterocycles |
| TW280819B (de) * | 1993-11-17 | 1996-07-11 | Sumitomo Pharma | |
| US5801168A (en) * | 1994-06-09 | 1998-09-01 | Zeneca Limited | Substituted nitrogen heterocycles |
| JP4224566B2 (ja) | 2000-12-18 | 2009-02-18 | 株式会社医薬分子設計研究所 | 炎症性サイトカイン産生遊離抑制剤 |
| CN100410236C (zh) * | 2002-01-29 | 2008-08-13 | 雪兰诺实验室有限公司 | 作为蛋白酪氨酸磷酸酶调节剂的取代亚甲基酰胺衍生物 |
| GB0217920D0 (en) * | 2002-04-23 | 2002-09-11 | Aventis Pharm Prod Inc | Interleukin-4 Gene Expression inhibitors |
| CA2488363C (en) | 2002-06-06 | 2011-01-04 | Institute Of Medicinal Molecular Design, Inc. | O-substituted hydroxyaryl derivatives |
| EA009701B1 (ru) | 2002-06-06 | 2008-02-28 | Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. | Противоаллергические средства |
| US20060035944A1 (en) * | 2002-06-11 | 2006-02-16 | Susumu Muto | Remedies for neurodegenerative diseases |
| MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
| ES2315877T3 (es) | 2004-06-18 | 2009-04-01 | Biolipox Ab | Indoles utiles en el tratamiento de inflamaciones. |
| DE602005008084D1 (de) * | 2004-08-24 | 2008-08-21 | Janssen Pharmaceutica Nv | Als antikonvulsive mittel geeignete neue benzokondensierte heteroarylsulfamidderivate |
| CN101142185A (zh) | 2005-01-19 | 2008-03-12 | 比奥里波克斯公司 | 用于炎症治疗的吲哚 |
| KR20080012360A (ko) | 2005-05-20 | 2008-02-11 | 얀센 파마슈티카 엔.브이. | 설파미드 유도체의 제조 방법 |
| AU2006249866B2 (en) | 2005-05-26 | 2011-10-13 | Aldeyra Therapeutics, Inc. | Compositions and methods of treating retinal disease |
| US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
| US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
| US8492431B2 (en) | 2005-12-19 | 2013-07-23 | Janssen Pharmaceutica, N.V. | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
| US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
| EA200870556A1 (ru) | 2006-05-19 | 2009-06-30 | Янссен Фармацевтика Н.В. | Комбинированная терапия в лечении эпилепсии и родственных расстройств |
| EA018567B1 (ru) | 2008-06-23 | 2013-08-30 | Янссен Фармацевтика Нв | Кристаллическая форма (2s)-(-)-n-(6-хлор-2,3-дигидробензо[1,4]диоксин-2-илметил)сульфамида |
| US8815939B2 (en) | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
| WO2011072141A1 (en) | 2009-12-11 | 2011-06-16 | Neuron Systems, Inc. | Compositions and methods for the treatment of macular degeneration |
| AU2013361314A1 (en) | 2012-12-20 | 2015-07-02 | Aldeyra Therapeutics, Inc. | Peri-carbinols |
| CN117045653A (zh) | 2013-01-23 | 2023-11-14 | 奥尔德拉医疗公司 | 与毒性醛相关的疾病和治疗 |
| US10111862B2 (en) | 2013-01-25 | 2018-10-30 | Aldeyra Therapeutics, Inc. | Traps in the treatment of macular degeneration |
| US10550085B2 (en) | 2015-08-21 | 2020-02-04 | Aldeyra Therapeutics, Inc. | Deuterated compounds and uses thereof |
| CA3022665A1 (en) | 2016-05-09 | 2017-11-16 | Aldeyra Therapeutics, Inc. | Combination treatment of ocular inflammatory disorders and diseases |
| CA3054811A1 (en) | 2017-03-16 | 2018-09-20 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
| WO2019075136A1 (en) | 2017-10-10 | 2019-04-18 | Aldeyra Therapeutics, Inc. | TREATMENT OF INFLAMMATORY DISORDERS |
| AU2019319740A1 (en) | 2018-08-06 | 2021-03-25 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
| JP2022530967A (ja) | 2019-05-02 | 2022-07-05 | アルデイラ セラピューティクス， インコーポレイテッド | 多形化合物およびその使用 |
| WO2020223717A1 (en) | 2019-05-02 | 2020-11-05 | Aldeyra Therapeutics, Inc. | Process for preparation of aldehyde scavenger and intermediates |
| WO2021231792A1 (en) | 2020-05-13 | 2021-11-18 | Aldeyra Therapeutics, Inc. | Pharmaceutical formulations and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60123485A (ja) * | 1983-12-08 | 1985-07-02 | Yoshitomi Pharmaceut Ind Ltd | インド−ル−３−カルボキサミド誘導体 |
| US4675332A (en) * | 1984-12-10 | 1987-06-23 | Warner-Lambert Company | Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents |
| NZ222878A (en) * | 1986-12-17 | 1991-02-26 | Merck Frosst Canada Inc | 3-hetero-substituted-n-benzyl-indole derivatives, and pharmaceutical compositions |
-
1991
- 1991-10-28 AU AU86760/91A patent/AU641052B2/en not_active Expired
- 1991-10-28 CA CA002054339A patent/CA2054339C/en not_active Expired - Lifetime
- 1991-10-29 NZ NZ240380A patent/NZ240380A/en not_active IP Right Cessation
- 1991-10-30 IL IL9990891A patent/IL99908A/en not_active IP Right Cessation
- 1991-10-31 JP JP32157391A patent/JP3168565B2/ja not_active Expired - Lifetime
- 1991-10-31 PT PT99400A patent/PT99400B/pt not_active IP Right Cessation
- 1991-10-31 FI FI915146A patent/FI102676B/fi not_active IP Right Cessation
- 1991-11-01 NO NO914300A patent/NO177139C/no not_active IP Right Cessation
- 1991-11-01 HU HU913454A patent/HU214597B/hu unknown
- 1991-11-01 IE IE383491A patent/IE913834A1/en not_active IP Right Cessation
- 1991-11-01 KR KR1019910019414A patent/KR100220882B1/ko not_active Expired - Lifetime
- 1991-11-04 EP EP91118738A patent/EP0483881B1/de not_active Expired - Lifetime
- 1991-11-04 DE DE69128764T patent/DE69128764T2/de not_active Expired - Lifetime
- 1991-11-04 AT AT91118738T patent/ATE162519T1/de not_active IP Right Cessation
- 1991-11-04 ES ES91118738T patent/ES2113359T3/es not_active Expired - Lifetime
- 1991-11-04 DK DK91118738.3T patent/DK0483881T3/da active
-
1998
- 1998-03-13 GR GR980400534T patent/GR3026349T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE162519T1 (de) | 1998-02-15 |
| GR3026349T3 (en) | 1998-06-30 |
| EP0483881A1 (de) | 1992-05-06 |
| JPH0733737A (ja) | 1995-02-03 |
| HU913454D0 (en) | 1992-01-28 |
| KR100220882B1 (ko) | 1999-09-15 |
| PT99400B (pt) | 1999-04-30 |
| PT99400A (pt) | 1992-09-30 |
| FI102676B1 (fi) | 1999-01-29 |
| EP0483881B1 (de) | 1998-01-21 |
| NO914300L (no) | 1992-05-04 |
| JP3168565B2 (ja) | 2001-05-21 |
| FI915146L (fi) | 1992-05-03 |
| DK0483881T3 (da) | 1998-03-16 |
| IE913834A1 (en) | 1992-05-22 |
| HUT59668A (en) | 1992-06-29 |
| DE69128764D1 (de) | 1998-02-26 |
| ES2113359T3 (es) | 1998-05-01 |
| CA2054339C (en) | 2002-12-24 |
| NZ240380A (en) | 1994-05-26 |
| NO914300D0 (no) | 1991-11-01 |
| CA2054339A1 (en) | 1992-05-03 |
| FI102676B (fi) | 1999-01-29 |
| AU8676091A (en) | 1992-05-07 |
| KR920009796A (ko) | 1992-06-25 |
| IL99908A0 (en) | 1992-08-18 |
| HU214597B (hu) | 1998-04-28 |
| NO177139B (no) | 1995-04-18 |
| DE69128764T2 (de) | 1998-06-04 |
| FI915146A0 (fi) | 1991-10-31 |
| AU641052B2 (en) | 1993-09-09 |
| IL99908A (en) | 1995-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO177139C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-amidoindolylderivater | |
| NO179584C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler | |
| FI881103A0 (fi) | Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi | |
| NO168353C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(2'-aminofenyl)-benzamidderivater | |
| FI881874A7 (fi) | Menetelmä terapeuttisesti aktiivisten N-(pyridyyli)-1H-indoli-1-amiinien valmistamiseksi | |
| FI925871L (fi) | Menetelmä terapeuttisesti aktiivisten fenyyliguanidiinijohdannaisten valmistamiseksi | |
| NO177141C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive aminosyreantagonister | |
| FI894604L (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten pyridyyli- ja pyrimidyylipiperatsiinijohdannaisten valmistamiseksi | |
| FI904838A7 (fi) | Menetelmä farmaseuttisesti aktiivisten karboksitetrahydroisokinoliinien ja niiden johdannaisten valmistamiseksi | |
| NO175976C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater | |
| NO176100C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive oksodihydropyridyl- og oksodihydropyridazinylkromanderivater | |
| NO174203C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive | |
| FI901883A0 (fi) | Menetelmä terapeuttisesti vaikuttavien 2-substituoitujen N,N'-ditrimetoksibentsoyylipiperatsiinien valmistamiseksi | |
| FI892946A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 2,3,4,5-tetrahydro-1H-3-bentsoatsepiinijohdannaisten valmistamiseksi | |
| FI98456B (fi) | Menetelmä terapeuttisesti aktiivisten 1-piperidinyylialkanoyyliaryylisulfonamidijohdannaisten valmistamiseksi | |
| FI893682L (fi) | Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi | |
| FI922835L (fi) | Menetelmä terapeuttisesti aktiivisten piperidiinijohdannaisten valmistamiseksi | |
| IT1239064B (it) | Uso terapeutico del dipiridamolo | |
| FI922267L (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 3-isoksatsolyyli-4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi | |
| FI97388B (fi) | Menetelmä heterosyklisten NMDA-antagonistien valmistamiseksi | |
| NO178375C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive NMDA-antagonister | |
| BE871029A (fr) | Benzylideneaniline et ses derives, utilises pour le traitement d'inflammation chez les animaux a sang chaud | |
| NO961910L (no) | Fremgangsmåte for fremstilling av terapeutisk aktive polyamider | |
| SE8904189D0 (sv) | Anordning foer straeckbehandling av en maenniskas rygg | |
| NO174958C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive tetralinderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |